Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116

Anticancer Research

Volumn 30, Issue 11, 2010, Pages 4537-4545

  Wang, Zuguang ^a   Chen, Hong ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Colon cancer cells; DLD 1; Epigenetic regulation; Genistein; Soy isoflavone; SW480; WNT5a promoter

Indexed keywords

BISULFITE; GENISTEIN; MESSENGER RNA; WNT3A PROTEIN; WNT5A PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER STAGING; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME;

ANTICARCINOGENIC AGENTS; CELL PROLIFERATION; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; WNT PROTEINS;

EID: 78650240296     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. American Cancer Society. Cancer Facts & Figures 2009; 2009.
2. IARC. Cancer incidence in five continents. Volume IX. IARC Sci Publ (160): 1-837, 2008.
3. MacDonald RS, Guo J, Copeland J, Browning JD Jr., Sleper D, Rottinghaus GE et al: Environmental influences on isoflavones and saponins in soybeans and their role in colon cancer. J Nutr 135(5): 1239-1242, 2005. (Pubitemid 40638335)
4. Messina M and Bennink M: Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data. Baillieres Clin Endocrinol Metab 12(4): 707-728, 1998. (Pubitemid 29261279)
5. Toyomura K and Kono S: Soybeans, soy foods, isoflavones and risk of colorectal cancer: a review of experimental and epidemiological data. Asian Pac J Cancer Prev 3(2): 125-132, 2002.
6. Linsalata M, Russo F, Notarnicola M, Guerra V, Cavallini A, Clemente C et al: Effects of Genistein on the Polyamine Metabolism and Cell Growth in DLD-1 Human Colon Cancer Cells. Nutr Cancer 52(1): 84-93, 2005. (Pubitemid 41232653)
7. Yu J, Cheng Y, Xie L and Zhang R: Effects of genistein and daidzein on membrane characteristics of HCT cells. Nutr Cancer 33(1): 100-104, 1999.
8. Zhu Q, Meisinger J, Van Thiel DH, Zhang Y and Mobarhan S: Effects of soybean extract on morphology and survival of Caco-2, SW620, and HT-29 cells. Nutr Cancer 42(1): 131-140, 2002.
9. Kim EJ, Shin HK and Park JH: Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein. J Med Food 8(4): 431-438, 2005.
10. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE et al: Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFkappaB. FASEB J 20(12): 2136-2138, 2006.
11. Bises G, Bajna E, Manhardt T, Gerdenitsch W, Kallay E and Cross HS: Gender-specific modulation of markers for premalignancy by nutritional soy and calcium in the mouse colon. J Nutr 137(1): 211S-215S, 2007.
12. Cross HS, Lipkin M and Kallay E: Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J Nutr 136(3): 561-564, 2006.
13. Lechner D, Bajna E, Adlercreutz H and Cross HS: Genistein and 17beta-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells. Anticancer Res 26(4A): 2597-2603, 2006.
14. INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11(19 Pt 1): 7033-7041, 2005.
15. Fang MZ, Jin Z, Wang Y, Liao J, Yang GY, Wang LD et al: Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int J Oncol 26(3): 615-622, 2005.
16. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y et al: Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 123(3): 552-560, 2008.
17. INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res 68(8): 2736-2744, 2008.
18. Day JK, Bauer AM, DesBordes C, Zhuang Y, Kim BE, Newton LG et al: Genistein alters methylation patterns in mice. J Nutr 132(8 Suppl): 2419S-2423S, 2002.
19. Dolinoy DC, Huang D and Jirtle RL: Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci 104(32): 13056-13061, 2007.
20. Dolinoy DC, Weidman JR, Waterland RA and Jirtle RL: Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. EnvironHealth Perspect 114(4): 567-572, 2006.
21. Cadigan KM and Nusse R: Wnt signaling: a common theme in animal development. Genes Dev 11(24): 3286-3305, 1997.
22. Logan CY and Nusse R: The WNT signaling pathway in development and disease. Ann Rev Cell Dev Biol 20(1): 781-810, 2004.
23. Nusse R and Varmus HE: Wnt genes. Cell 69(7): 1073-1087, 1992.
24. 2+ pathways. Oncogene 18(55): 7860-7872, 1999.
25. Widelitz R: Wnt signaling through canonical and non-canonical pathways recent progress. Growth Factor 23(2): 111-116, 2005.
26. Fathke C, Wilson L, Shah K, Kim B, Hocking A, Moon R et al: Wnt signaling induces epithelial differentiation during cutaneous wound healing. BMC Cell Biol 7: 4, 2006.
27. Watt FM: Unexpected Hedgehog-Wnt interactions in epithelial differentiation. Trends Mol Med 10(12): 577-580, 2004.
28. Gregorieff A and Clevers H: Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19(8): 877-890, 2005.
29. Pinto D and Clevers H: Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res 306(2): 357-363, 2005.
30. Pinto D and Clevers H: Wnt, stem cells and cancer in the intestine. Biol Cell 97(3): 185-196, 2005.
31. Giles RH, van Es JH and Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653(1): 1-24, 2003.
32. Hendriks B and Reichmann E: Wnt signaling: a complex issue. Biol Res 35(2): 277-286, 2002.
33. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J et al: Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25(29): 4116-4121, 2006.
34. Cairns P and Adams PD: Clipped wings: epigenetic inactivation of APC. Cancer Biol Ther 3(10): 965-966, 2004.
35. Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK and Albertsen H: APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res 5(2): 165-170, 2007.
36. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD et al: Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36(4): 417-422, 2004.
37. Su Y, Simmen FA, Xiao R and Simmen RCM: Expression profiling of rat mammary epithelial cells reveals candidate signaling pathways in dietary protection from mammary tumors. Physiol Genomics 30: 8-16, 2007.
38. Su Y and Simmen RCM: Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates {beta}-catenin signaling in mammary epithelial cells. Carcinogenesis 30(2): 331-339, 2009.
39. Katoh M: WNT/PCP signaling pathway and human cancer (review). Oncol Rep 14(6): 1583-1588, 2005.
40. Mikels AJ and Nusse R: Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4(4): e115, 2006.
41. McDonald SL and Silver A: The opposing roles of Wnt-5a in cancer. Br J Cancer 101(2): 209-214, 2009.
42. Dejmek J, Dejmek A, Safholm A, Sjolander A and Andersson T: Wnt-5a protein expression in primary Dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 65(20): 9142-9146, 2005.
43. Leibovitz A, Stinson JC, McCombs WB, III, McCoy CE, Mazur KC and Mabry ND: Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36(12): 4562-4569, 1976.
44. Guo JY, Li X, Browning JD Jr, Rottinghaus GE, Lubahn DB, Constantinou A et al: Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer. J Nutr 134(1): 179-182, 2004.
45. Wagner J and Lehmann L: Estrogens modulate the gene expression of Wnt-7a in cultured endometrial adenocarcinoma cells. Mol Nutr Food Res 50(4-5): 368-372, 2006.
46. Shen J, Tai YC, Zhou J, Stephen Wong CH, Cheang PT, Fred Wong WS et al: Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling. Exp Hematol 35(1): 75-83, 2007.
47. Li M, Zhang Z, Hill DL, Chen X, Wang H and Zhang R: Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. Cancer Res 65(18): 8200-8208, 2005.
48. Xiao R, Badger T and Simmen F: Dietary exposure to soy or whey proteins alters colonic global gene expression profiles during rat colon tumorigenesis. Molec Cancer 4(1): 1, 2005.
49. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V et al: BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 30(4): 662-670, 2009.
50. Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S et al: Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-cell translocation gene 3 in prostate cancer. Cancer 116(1): 66-76, 2010.
51. Molinie B and Georgel P: Genetic and epigenetic regulations of prostate cancer by genistein. Drug News Perspect 22(5): 247-254, 2009.
52. Raynal NJ, Charbonneau M, Momparler LF and Momparler RL: Synergistic effect of 5-aza-2′-deoxycytidine and genistein in combination against leukemia. Oncol Res 17(5): 223-230, 2008.
53. Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, Dechelotte P et al: Soy Phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer Cells. In Vivo 24(4): 393-400, 2010.
54. Hibi K, Mizukami H, Goto T, Kitamura Y, Sakata M, Saito M et al: WNT5A gene is aberrantly methylated from the early stages of colorectal cancers. Hepatogastroenterology 56(93): 1007-1009, 2009.
55. Ying, J, Li, H, Yu, J, Ng, KM, Poon, FF, Wong, SCC et al: WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/β-catenin signaling, and is frequently methylated in colorectal cancer. Clinical Cancer Res 14(1): 55-61, 2008.